文献速递区域麻醉与超声疼痛医学

大鼠硬膜外注射脂质体前列腺素E1激动剂的神经安全性

The Neurological Safety of an Epidurally Administered Lipo-PGE1 Agonist in Rats.
PubMed 文献 · Reg Anesth Pain Med · 2017-01-01

结果显示脂质体前列腺素E1激动剂组除一只大鼠外神经学评估正常,组织病理学未见退行性脊髓病、染色质溶解或髓鞘丢失,而酒精组全部出现感觉运动缺陷和组织病理学异常,提示该药在大鼠硬膜外注射具有神经安全性。

要点

  • 脂质体前列腺素E1激动剂硬膜外注射未引起明显神经学异常。
  • 组织病理学未见脊髓或背根神经节退行性改变。
  • 阳性对照酒精组全部出现神经损伤,验证模型有效性。

核心结论

  • 脂质体前列腺素E1激动剂在大鼠硬膜外注射未引起明显脊髓或背根神经节神经学异常,提示在该物种中具有神经安全性。

主要发现

  • 脂质体前列腺素E1激动剂组除一只大鼠外,其余神经学评估均正常。
  • 脂质体前列腺素E1激动剂组和阴性对照组在任何时间点均无退行性脊髓病、染色质溶解或髓鞘丢失的组织病理学证据。
  • 阳性对照组所有大鼠均出现感觉和运动缺陷以及组织病理学异常。

临床怎么用

  • 该动物实验结果为脂质体前列腺素E1激动剂硬膜外给药提供了初步神经安全性证据,但尚需进一步哺乳动物研究验证。

局限性

  • 研究仅在大鼠中进行,样本量较小(每组9只),需额外哺乳动物研究确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Liposomal prostaglandin E1 (Lipo-PGE1) can inhibit platelet aggregation and vasodilatation and has been found to be therapeutic in ischemia and spinal diseases including stenosis. However, the neurologic safety of epidural administration of lipo-PGE1 requires further study. We investigated the neurotoxicity of epidurally administered lipo-PGE1 agonist in rats. METHODS: Twenty-seven rats were randomly divided into three groups: Epidural isotonic sodium chloride solution administration (negative control, group N, n = 9); epidural lipo-PGE1 agonist (group L, n = 9); and epidural alcohol (positive control, group A, n = 9). A single 3-mL injection of lipo-PGE1 agonist (0.3 mL, 0.15 μg/kg), 40% ethanol, or isotonic sodium chloride solution was administered. Neurologic assessments were performed 3, 7, and 21 days after the injection. Histopathologic data were evaluated by one pathologist via light microscopy. RESULTS: All rats in groups N and L, except one rat in group L, demonstrated normal response to neurologic assessments. Histopathologic findings showed no evidence of degenerative myelopathy, chromatolysis, or myelin loss in group N or L at any time point. However, all rats in group A revealed sensory and motor deficits as well as histopathologic abnormalities. CONCLUSION: Liposomal prostaglandin E1 agonist did not cause any apparent neurologic abnormalities in the spinal cord or dorsal root ganglion, suggesting it is neurologically safe for epidural injection in this species. Additional mammalian study is warranted.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Choi E, Im SM, Yoo HS, et al. The Neurological Safety of an Epidurally Administered Lipo-PGE1 Agonist in Rats. Reg Anesth Pain Med. 2017. PMID: 27922949. doi:10.1097/AAP.0000000000000520

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。